Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.

David N. Gilbert

doi:10.1086/591391

Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.

David N. Gilbert

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of community-acquired pneumonia.

Original language	English
Pages (from-to)	S121-122
Journal	Clinical Infectious Diseases
Volume	47 Suppl 3
DOIs	https://doi.org/10.1086/591391
State	Published - Dec 1 2008

Access to Document

10.1086/591391

Cite this

@article{41775cc0b70a4033aed28c04e17efe62,

title = "Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.",

abstract = "A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of community-acquired pneumonia.",

author = "Gilbert, \{David N.\}",

note = "Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs for the Treatment of Community-Acquired Pneumonia,” sponsored by the US Food and Drug Administration and the Infectious Diseases Society of America.",

year = "2008",

month = dec,

day = "1",

doi = "10.1086/591391",

language = "English",

volume = "47 Suppl 3",

pages = "S121--122",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Scenario 1

T2 - a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.

AU - Gilbert, David N.

N1 - Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs for the Treatment of Community-Acquired Pneumonia,” sponsored by the US Food and Drug Administration and the Infectious Diseases Society of America.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of community-acquired pneumonia.

AB - A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of community-acquired pneumonia.

UR - https://www.scopus.com/pages/publications/58149234323

U2 - 10.1086/591391

DO - 10.1086/591391

M3 - Article

C2 - 18986276

AN - SCOPUS:58149234323

SN - 1058-4838

VL - 47 Suppl 3

SP - S121-122

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

ER -

Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this